Abstract
A preliminary announcement of a new in vitro blood test for cancer by Field and Caspary appeared in the Lancet of 26 December 1970. The test depends on sensitization of the patient's lymphocytes to a common antigen apparently present in human tumours. We now offer independent confirmation of these findings, together with methods for improving the test towards its future clinical use.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Pritchard, J., Moore, J., Sutherland, W. et al. Evaluation and Development of the Macrophage Electrophoretic Mobility (MEM) Test for Malignant Disease). Br J Cancer 27, 1–9 (1973). https://doi.org/10.1038/bjc.1973.1
Issue Date:
DOI: https://doi.org/10.1038/bjc.1973.1
This article is cited by
-
Aspekte der immunologischen Diagnostik von Hirntumoren
Archiv für Psychiatrie und Nervenkrankheiten (1979)
-
Der Elektrophoretische-Mobilitäts- (EM) Test: Untersuchungsmethode zur Unterscheidung von malignen und nicht malignen Tumoren
Klinische Wochenschrift (1978)
-
Electrophoretic mobility (EM)-test for childhood cancer diagnosis
European Journal of Pediatrics (1977)
-
Der Elektrophorese-Mobilit�ts-Test in der Diagnostik von Malignomen
Zeitschrift f�r Krebsforschung und Klinische Onkologie (1976)
-
Der Makrophagen-Elektrophorese-Mobilitäts-LAD-Test als diagnostisches Verfahren für die multiple Sklerose
Journal of Neurology (1976)
